APV and multiple valuation of Global Blood Therapeutics
APV and multiple valuation of Global Blood Therapeutics (acquired by Pfizer)
16Discussadd_shopping_cart
$150.00
by Felix Liebold
Have a ready-to-use Best Practice you would like to share?
Publish a Best Practice